Pfizer Inc. and German partner BioNTech SE said Friday they have initiated rolling submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccine in individuals 16 years of age and older. The vaccine was already granted emergency use...
Pfizer (NYSE:PFE) DOWN 1.52% AT 5238.20 Pfizer Inc on Tuesday forecast $26 billion in sales of the COVID-19 vaccine this year, an increase of more than 70% from its last projection and a reflection of the growing global vaccination drive. The vaccine, which it co-developed with Germany’s BioNTech SE...
Pfizer (NYSE:PFE) UP 0.05% AT 38.66 Israel’s Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer (NYSE:PFE)’s COVID-19 vaccine, though it has not yet drawn any conclusions. Pfizer said it has not observed a higher rate...